CAPPED REVERSE BONUS ZERTIFIKAT - FRESENIUS Stock

Certificat

DE000GQ2XR81

Real-time BOERSE MUENCHEN 06:11:36 2024-07-17 am EDT
34.75 EUR -0.54% Intraday chart for CAPPED REVERSE BONUS ZERTIFIKAT - FRESENIUS
Current month-1.99%
1 month+2.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-17 34.75 -0.54%
24-07-16 34.94 -0.91%
24-07-15 35.26 -0.34%
24-07-12 35.38 -0.42%
24-07-11 35.53 +0.20%

Real-time BOERSE MUENCHEN

Last update July 17, 2024 at 06:11 am EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellPUT
Underlying FRESENIUS SE & CO. KGAA
Issuer Goldman Sachs
WKN GQ2XR8
ISINDE000GQ2XR81
Date issued 2023-08-24
Strike 12
Maturity 2024-12-20 (157 Days)
Parity 1 : 1
Emission price 28
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 35.77
Lowest since issue 26.6
Spread 0.03
Spread %0.09%

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
29.56 EUR
Average target price
37.54 EUR
Spread / Average Target
+27.00%
Consensus